Cholesterol News and Research

RSS

Cholesterol is a waxy, fat-like substance made in the liver, and found in the blood and in all cells of the body. Cholesterol is important for good health and is needed for making cell walls, tissues, hormones, vitamin D, and bile acid.

Researchers uncover key bacteria driving success of fecal microbiota transplants

Fecal microbiota transplants, or FMTs, are a magic bullet for patients with recurring infections from Clostridioides difficile (C. diff), but researchers are only beginning to understand why.

9 Oct 2024

The new science behind the health benefits of caffeine

A study reveals caffeine's potential to enhance heart health by improving endothelial function in systemic lupus erythematosus patients through EPC survival.

9 Oct 2024

Caffeine's anti-inflammatory effects may help protect blood vessels

A new paper in Rheumatology, published by Oxford University Press, finds that consuming more caffeine may improve heart health.

9 Oct 2024

High-fiber diets transform gut microbiome, improving health across multiple diseases

Researchers identified two competing guilds of gut bacteria, one beneficial and one harmful, which can predict health outcomes and treatment success in diseases like type 2 diabetes.

8 Oct 2024

Liver X receptor beta offers new hope in treating depression and anxiety

Liver X receptor beta (LXRβ) shows potential in reducing depression and anxiety by improving neurogenesis, reducing neuroinflammation, and enhancing cognitive and emotional function. More research on LXR agonists could reveal new treatments for mental health disorders.

8 Oct 2024

Eating more beans leads to weight loss and better nutrition

Adults who consume beans show higher intake of essential nutrients, better diet quality, and improved weight outcomes, highlighting the health benefits of beans.

8 Oct 2024

Survey: Most Americans skeptical about weight-loss injections

A new national survey shows that, despite intense marketing, most Americans do not want the new weight-loss injectables, such as Wegovy and Ozempic.

8 Oct 2024

Researchers discover effective treatment strategy for lethal glioblastoma

Glioblastoma (GBM) is the most lethal brain tumor, with a median survival rate of merely 12-16 months after diagnosis. Despite surgical, radiation and chemotherapy treatments, the two-year survival rate for GBM patients is less than 10%.

7 Oct 2024

British adults in midlife show better cardiovascular health than American counterparts

Rates of obesity, high blood pressure and high cholesterol are lower among British adults in their 30s and 40s compared to their counterparts in the US, according to a new study led by UCL researchers.

7 Oct 2024

US adults face worse midlife health compared to British counterparts

A study reveals poorer cardiometabolic health in middle-aged Americans compared to Brits, highlighting the impact of socioeconomic status on health outcomes.

7 Oct 2024

Study sheds light on a potential new strategy to prevent fatty liver

The accumulation of fats in the liver is driven by high-fat diets and obesity, and is becoming an increasingly prevalent global health concern.

7 Oct 2024

LXRβ emerges as a promising target for depression and anxiety treatments

In a state-of-the-art Bench to Bedside review published in the journal Brain Medicine (Genomic Press), researchers Dr. Xiaoyu Song and Professor Jan-Åke Gustafsson from the University of Houston and Karolinska Institutet (Sweden) shed light on the therapeutic potential of liver X receptor beta (LXRβ) in treating depression and anxiety.

4 Oct 2024

Could eating eggs prevent dementia?

Daily egg consumption may reduce the risk of dementia in older adults, but consuming more than two eggs daily or no eggs at all shows no significant benefit. More research is needed to explore the effects of egg consumption on cognitive health.

3 Oct 2024

Atherosclerosis progression associated with increased risk of death in asymptomatic individuals

The progression of atherosclerosis in people who have no symptoms of it is independently associated with the risk of dying from any cause, according to a new study led by researchers from Mount Sinai Fuster Heart Hospital, published September 30 in the Journal of the American College of Cardiology.

1 Oct 2024

Time-restricted eating could offer health benefits to adults with metabolic syndrome

More than one-third of adults in the United States have metabolic syndrome, a cluster of conditions that significantly raise a person's risk of heart disease, stroke, and type 2 diabetes.

1 Oct 2024

Collaborative initiative seeks to uncover ways to reduce Alzheimer’s and dementia risk

The Triangulation of Innovative Methods to End Alzheimer's Disease project will use large, diverse datasets to examine whether interventions targeting alcohol use, depression, vision or hearing impairments, or social isolation can protect people from Alzheimer's disease and related dementias.

30 Sep 2024

Atherosclerosis burden and progression predict all-cause mortality

A study carried out at Mount Sinaí Fuster Heart Hospital in New York in collaboration with the Centro Nacional de Investigaciones Cardiovasculares (CNIC) in Madrid provides important new information about atherosclerosis, a disease in which lipids (cholesterol) and other substances accumulate in plaques on the arterial wall, causing the vessels to harden and narrow, and increasing the risk of severe cardiovascular conditions.

30 Sep 2024